HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mette H Jensen Selected Research

gastric inhibitory polypeptide (3-30)-amide

5/2021Effects of endogenous GIP in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mette H Jensen Research Topics

Disease

1Type 2 Diabetes Mellitus (MODY)
05/2021
1Bone Resorption
05/2021
1Malaria
10/2019
1Epilepsy (Aura)
10/2014
1Nervous System Diseases (Neurological Disorders)
10/2014

Drug/Important Bio-Agent (IBA)

1Peptides (Polypeptides)IBA
05/2021
1gastric inhibitory polypeptide receptorIBA
05/2021
1Glucose (Dextrose)FDA LinkGeneric
05/2021
1CollagenIBA
05/2021
1gastric inhibitory polypeptide (3-30)-amideIBA
05/2021
1LipidsIBA
10/2019
1VaccinesIBA
10/2019
1saponin QA-21V1 (QS21)IBA
10/2019
1EmulsionsIBA
10/2019
1Aluminum Hydroxide (Algeldrate)FDA Link
10/2019
1GABA Plasma Membrane Transport ProteinsIBA
10/2014
1Aminobutyrates (Aminobutyric Acid)IBA
10/2014
1Pharmaceutical PreparationsIBA
10/2014
1Proteins (Proteins, Gene)FDA Link
10/2014
1Membrane Transport Proteins (Biological Pump)IBA
10/2014

Therapy/Procedure

1Intramuscular Injections
10/2019